Filing Details

Accession Number:
0001729197-18-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-11 17:22:21
Reporting Period:
2018-12-10
Accepted Time:
2018-12-11 17:22:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534120 Cerecor Inc. CERC Pharmaceutical Preparations (2834) 450705648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1729197 V Matthew Phillips C/O Cerecor Inc.
400 E. Pratt Street, Suite 606
Baltimore MD 21202
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-10 497 $2.85 497 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $1.13 2027-11-17 100,000 100,000 Direct
Common Stock Stock Option (right to buy) $3.21 2028-01-22 100,000 100,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-11-17 100,000 100,000 Direct
2028-01-22 100,000 100,000 Direct
Footnotes
  1. These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
  2. The grant shall vest one-fourth on each of the first, second, third and fourth anniversaries of the date of grant, provided Mr. Phillips is then an officer of the Company.